Last Updated: June 9, 2026

Actavis Totowa Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS TOTOWA

ACTAVIS TOTOWA has twenty-two approved drugs.

Summary for Actavis Totowa

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	22

Drugs and US Patents for Actavis Totowa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Totowa	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	078589-003	Nov 18, 2015	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Actavis Totowa Teva	FINASTERIDE	finasteride	TABLET;ORAL	077914-001	Mar 28, 2007		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Actavis Totowa	GEMCITABINE HYDROCHLORIDE	gemcitabine hydrochloride	INJECTABLE;INJECTION	079160-003	Jul 28, 2016		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Actavis Totowa	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	071766-001	Oct 5, 1987	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Actavis Totowa	TOPOTECAN HYDROCHLORIDE	topotecan hydrochloride	INJECTABLE;INJECTION	090620-001	Dec 2, 2010	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Actavis Totowa	TOPIRAMATE	topiramate	TABLET;ORAL	078637-004	Feb 27, 2013		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Actavis Totowa	REPAGLINIDE	repaglinide	TABLET;ORAL	090008-001	Jan 22, 2014		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.